2 abril 2015
By engineering antibacterial enzymes, investigators are using novel strategies to target the prevalent drug-resistant bacterium Staphylococcus aureus. «Antibacterial enzymes, which kill via catalytic mechanisms, represent promising candidates in the fight against drug-resistant microbes,» explained the lead researcher. «Staph infections in hospital settings are a serious problem that has gained widespread public attention, and there’s an urgent need to address the threat of antibiotic resistance. Using molecular engineering, we are expanding the pool of antibacterial drug candidates and improving their performance.»
http://feeds.sciencedaily.com/~r/sciencedaily/~3/gl3vK8J3uPA/150402161535.htm
